Search Results 51-60 of 16077 for pharmacogenetics
Pharmacogenetics of cardiovascular drugs. Curr Opin Cardiol. 2023 May 1; 38 (3):207-214 Epub 2023 Mar 28. View PubMed; Ingraham BS, Farkouh ME, Lennon RJ, So ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. The goal of this study is to examine the current and (potential) future therapeutic relevance of PGx testing in established patients with ...
Data used in the study came from a collaboration between Mayo Clinic and the Pharmacogenetics of Methotrexate in Rheumatoid Arthritis (PAMERA) consortium, that ...
The five-year study expands previous pharmacogenetic ... Karpyak. Applying pharmacogenetics for an individualized treatment approach on a large scale.
The Pharmacology Shared Resource provides preclinical and clinical pharmacologic and pharmacogenetic expertise and services to Mayo Clinic Comprensive ...
Chair2024 Scientific Program Subcommittee, Pharmacology, Pharmacogenetics and Pharmacogenomics Subcommittee, Experimental and Molecular Therapeutics Section.
Learn about the department and faculty of the PGY-2 Clinical Pharmacogenomics Residency at Mayo Clinic in Rochester, Minnesota.
“This association finding is a first step towards development of a pharmacogenetic test allowing physicians to choose appropriate treatment for specific ...
About this study. The goal of this study is to examine the current and (potential) future therapeutic relevance of PGx testing for a group of patients in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.